Jefferies downgraded IGM Biosciences (IGMS) to Hold from Buy with a price target of $2, down from $48, after the company ...

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell ...

IGM Biosciences (IGMS) is slashing its workforce by 73% and discontinuing development of two of its lead drug candidates in ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

The company is reducing its workforce by 73% and evaluating strategic alternatives to preserve shareholder value.

IgM and IgG antibodies against the dengue virus can be detected in most patients five days after the onset of symptoms. IgG can be measured for many months and even years after a dengue infection.